Althagafi Abdulhamid, Alshibani Mohannad, Alshehri Samah, Alqarni Abdulrahman, Baharith Mohammed, Alqurashi Salih
Pharmacy Practice, King Abdulaziz University, Jeddah, SAU.
Clinical Pharmacy, King Abdulaziz University, Jeddah, SAU.
Cureus. 2023 Aug 14;15(8):e43477. doi: 10.7759/cureus.43477. eCollection 2023 Aug.
The administration of multiple medications and complex drug regimens has increased medication-related problems (MRPs) and associated factors. MRPs can occur at any stage of the medication process and are common after hospital discharge. Understanding and managing these problems are crucial for promoting safe and effective medication use.
This study aimed to evaluate the prevalence of MRPs among post-discharge patients with high medication risk in the academic tertiary care hospital of King Abdulaziz University (KAUH) in Jeddah, Saudi Arabia.
A prospective cross-sectional study was conducted, and data were collected through phone calls to discharged patients using validated questions. MRPs were identified based on the classification of the Pharmaceutical Care Network Europe (PCNE), and data analysis was performed using descriptive statistics.
Out of 287 screened participants, 201 fulfilled the inclusion criteria. The prevalence of MRPs among high-medication-risk patients after hospital discharge was substantial, with 519 MRPs identified. The most common types of MRPs were the need for medication information, untreated symptoms or indications, and nonadherence.
The most prevalent MRPs among patients in our hospital were the need for education and untreated symptoms or indications. Future studies should investigate MRPs in larger samples and explore interventions by pharmacists.
多种药物及复杂用药方案的使用增加了用药相关问题(MRP)及其相关因素。MRP可发生在用药过程的任何阶段,且在出院后很常见。了解并管理这些问题对于促进安全、有效的药物使用至关重要。
本研究旨在评估沙特阿拉伯吉达阿卜杜勒阿齐兹国王大学(KAUH)学术三级医疗中心出院后高用药风险患者中MRP的患病率。
开展了一项前瞻性横断面研究,通过电话联系出院患者,使用经过验证的问题收集数据。根据欧洲药学保健网络(PCNE)的分类确定MRP,并使用描述性统计进行数据分析。
在287名筛查参与者中,201名符合纳入标准。出院后高用药风险患者中MRP的患病率很高,共识别出519个MRP。最常见的MRP类型是需要用药信息、症状或适应证未得到治疗以及不依从。
我院患者中最普遍的MRP是需要教育以及症状或适应证未得到治疗。未来的研究应在更大样本中调查MRP,并探索药剂师的干预措施。